Goodwin

Blake Liggio

Deals
4
Latest
Sep 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 4 deals
Deals by year
Blake Liggio: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Blake Liggio was named on, most recent first
Sep 2026 Marea Therapeutics –Lisata TherapeuticsAcquisitionLegal adviser to Marea Therapeutics (target)Announced–Biotech+1Lisata Therapeutics acquisition of Marea Therapeutics
Jul 2026 Cherre –RealPageAcquisitionLegal adviser to Cherre (target)Completed–Software+2RealPage acquisition of Cherre
Apr 2026 Soleno Therapeutics –Neurocrine BiosciencesAcquisitionLegal adviser to Centerview Partners (target)Completed2,900.0Biotech+2Neurocrine Biosciences acquisition of Soleno Therapeutics
Apr 2026 Hodes Weill & Associates –Chatham FinancialAcquisitionLegal adviser to Hodes Weill & Associates (target)Completed–Investment banking and advisory+1Chatham Financial acquisition of Hodes Weill & Associates

Deals where Blake Liggio is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.